Literature DB >> 20494701

Yttrium-90 radioembolization in the management of liver malignancies.

Ahsun Riaz1, Laura M Kulik, Mary F Mulcahy, Robert J Lewandowski, Riad Salem.   

Abstract

Primary and secondary liver tumors are common. Locoregional therapies are establishing a role in the management of liver tumors due to the limited roles of surgical and systemic therapies. Our review presents some general concepts associated with yttrium-90 radioembolization and its specific utilization in various primary and secondary liver malignancies. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20494701     DOI： 10.1053/j.seminoncol.2010.03.006

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  6 in total

1.  Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?

Authors:  S Nahum Goldberg
Journal:  Radiology       Date:  2011-12       Impact factor: 11.105

Review 2.  Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.

Authors:  Andrew Kuei; Sammy Saab; Sung-Ki Cho; Stephen T Kee; Edward Wolfgang Lee
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

3.  Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicity.

Authors:  Olaguoke Akinwande; Veer Shah; Abigail Mills; Christopher Noda; Eric Weiner; Gretchen Foltz; Nael Saad
Journal:  Hepat Oncol       Date:  2017-10-30

Review 4.  Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.

Authors:  D P Al-Adra; R S Gill; S J Axford; X Shi; N Kneteman; S-S Liau
Journal:  Eur J Surg Oncol       Date:  2014-10-07       Impact factor: 4.424

5.  Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma.

Authors:  Nikhil T Sebastian; Yubo Tan; Eric D Miller; Terence M Williams; Dayssy Alexandra Diaz
Journal:  Clin Transl Radiat Oncol       Date:  2019-07-26

6.  Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review.

Authors:  Michael Feretis; Andriy Solodkyy
Journal:  World J Gastrointest Oncol       Date:  2020-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.